Skip to Content

Miconazole Pregnancy and Breastfeeding Warnings

Miconazole is also known as: Oravig

Medically reviewed on Jun 8, 2017

Miconazole Pregnancy Warnings

Miconazole has been assigned to pregnancy category C by the FDA. Animal studies have failed to reveal evidence of embryotoxicity, fetotoxicity, or teratogenicity during intravenous studies. There are no controlled data in human pregnancy. Miconazole is only recommended for use during pregnancy when there are no alternatives and benefit outweighs risk.

See references

Miconazole Breastfeeding Warnings

There are no data on the excretion of miconazole into human milk. The manufacturer recommends that caution be used when administering miconazole to nursing women.

See references

References for pregnancy information

  1. Weisberg M "Treatment of vaginal candidiasis in pregnant women." Clin Ther 8 (1986): 563-7
  2. "Product Information. Monistat (miconazole)." Ortho Pharmaceutical Corporation, Raritan, NJ.
  3. Rosa FW, Baum C, Shaw M "Pregnancy outcomes after first-trimester vaginitis drug therapy." Obstet Gynecol 69 (1987): 751-5
  4. Wallenburg HCS, Wladimiroff JW "Recurrence of vulvovaginal candidosis during pregnancy." Obstet Gynecol 48 (1976): 491-4
  5. "Product Information. ORAVIG (miconazole)." Strativa Pharmaceuticals, a Division of Par Pharmaceuticals, Inc., Woodcliff Lake, NJ.
  6. McNellis D, Facog, McLeod M, Lawson J, Pasquale SA "Treatment of vulvovaginal candidiasis in pregnancy." Obstet Gynecol 50 (1977): 674-8

References for breastfeeding information

  1. "Product Information. Monistat (miconazole)." Ortho Pharmaceutical Corporation, Raritan, NJ.
  2. "Product Information. ORAVIG (miconazole)." Strativa Pharmaceuticals, a Division of Par Pharmaceuticals, Inc., Woodcliff Lake, NJ.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide